FMP

FMP

Enter

QLGN - Qualigen T...

photo-url-https://images.financialmodelingprep.com/symbol/QLGN.png

Qualigen Therapeutics, Inc.

QLGN

NASDAQ

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

3.1 USD

0.04 (1.29%)

Build Up Free Cash Flow

Year

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

Revenue

607.64M

892.25M

1.06B

1.31B

1.43B

1.78B

2.22B

2.76B

3.44B

4.29B

Operating Cash Flow

29.18M

-54.96M

-9.98M

299.08M

320.56M

153.13M

190.78M

237.68M

296.12M

368.92M

Cap Ex

-3.19M

-13.06M

-23.82M

-7.34M

-14.92M

-20.82M

-25.94M

-32.31M

-40.26M

-50.16M

Free Cash Flow

25.98M

-68.02M

-33.8M

291.74M

305.64M

132.31M

164.84M

205.37M

255.86M

318.76M

Wacc

-

-

-

-

-

Pv Lfcf

-

-

-

-

-

Sum Pv Lfcf

-

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep